Universal monitoring of minimal residual disease in acute myeloid leukemia

BACKGROUND. Optimal management of acute myeloid leukemia (AML) requires monitoring of treatment response, but minimal residual disease (MRD) may escape detection. We sought to identify distinctive features of AML cells for universal MRD monitoring. METHODS. We compared genome-wide gene expression of...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JCI Insight
Main Authors: Coustan-Smith, Elaine, Song, Guangchun, Shurtleff, Sheila, Yeoh, Allen Eng-Juh, Chng, Wee Joo, Chen, Siew Peng, Rubnitz, Jeffrey E., Pui, Ching-Hon, Downing, James R., Campana, Dario
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Clinical Investigation 2018
Assuntos:
Clinical Medicine
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012500/
https://ncbi.nlm.nih.gov/pubmed/29720577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.98561
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares